Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics

被引：0
|
作者：
Gisondi, Paolo [1 ]
Bellinato, Francesco [1 ]
Idolazzi, Luca [2 ]
Zabotti, Alen [3 ,4 ]
McGonagle, Dennis [4 ,5 ]
Girolomoni, Giampiero [1 ]
机构：
[1] Univ Verona, Sect Dermatol, Verona, Italy
[2] Univ Verona, Sect Rheumatol, Verona, Italy
[3] Azienda Sanit Univ Friuli Cent, Udine, Italy
[4] NIHR Leeds Biomed Res Ctr, LTHT, Leeds, England
[5] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
D O I：
10.1093/bjd/ljae360.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FC29
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
    Solomon, Daniel H.
    Love, Thorvardur Jon
    Canning, Claire
    Schneeweiss, Sebastian
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2114 - 2117
  • [42] New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?
    Megna, Matteo
    Ocampo-Garza, Sonia Sofia
    Potestio, Luca
    Fontanella, Giuseppina
    Gallo, Lucia
    Cacciapuoti, Sara
    Ruggiero, Angelo
    Fabbrocini, Gabriella
    BIOMEDICINES, 2021, 9 (10)
  • [43] Biologics gone viral: Perceptions of biologics within online psoriasis and psoriatic arthritis communities
    Maynard, N.
    Mehta, M. D.
    Reddy, R.
    Yee, D.
    Zagona-Prizio, C.
    Khan, S.
    Khan, S.
    Armstrong, A. W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S55 - S55
  • [44] Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
    Philip J. Mease
    April W. Armstrong
    Drugs, 2014, 74 : 423 - 441
  • [45] Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
    Mease, Philip J.
    Armstrong, April W.
    DRUGS, 2014, 74 (04) : 423 - 441
  • [46] CARDIOVASCULAR RISK IN PSORIASIS AND PSORIATIC ARTHRITIS
    McInnes, Iain
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 3 - 3
  • [47] Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
    Vegas, Laura Pina
    Claudepierre, Pascal
    Sbidian, Emilie
    RHEUMATOLOGY, 2022, 61 (08) : E238 - E239
  • [48] Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics
    Gottlieb, Alice
    Korman, Neil J.
    Gordon, Kenneth B.
    Feldman, Steven R.
    Lebwohl, Mark
    Koo, John Y. M.
    Van Voorhees, Abby S.
    Elmets, Craig A. K.
    Leonardi, Craig L.
    Beutner, Karl R.
    Bhushan, Reva
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (05) : 851 - 864
  • [49] Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study: Reply
    Pina Vegas, Laura
    Claudepierre, Pascal
    Sbidian, Emilie
    RHEUMATOLOGY, 2022, 61 (10) : E321 - E322
  • [50] No Evidence of an Increased Risk of Serious Infections Among 3 Classes of Biologics for Psoriasis or Psoriatic Arthritis: A Retrospective Real-World Cohort Study
    Li, Xintong
    Andersen, Kathleen M.
    Chang, Hsien-Yen
    Alexander, G. Caleb
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345